Latest Cancer News

Palbociclib/Letrozole Improves Outcomes of Estrogen Receptor–Positive/HER2-Negative Advanced Breast Cancer (02-27-2015)
The results of the phase II PALOMA-1/TRIO-18 trial were recently reported in The Lancet Oncology and suggest that the addition of Ibrance® (palbociclib) to Femara® (letrozole) delayed the time to cancer... Continue Reading

FDA Grants Breakthrough Therapy Designation for MPDL3280A, an anti-PDL1 Investigational Cancer Immunotherapy for Non-Small Cell Lung Cancer (02-26-2015)
The investigational cancer immunotherapy MPDL3280A (anti-PDL1) has received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA). The designation was granted for the treatment... Continue Reading

Farydak® Approval Provides Another Treatment Option for Patients With Multiple Myeloma (02-25-2015)
Novartis announced today that the US Food and Drug Administration (FDA) has approved Farydak® (panobinostat) in combination with Velcade® and dexamethasone for the treatment of patients with multiple... Continue Reading

More Cancer News

Locations

Scarborough Office
100 Campus Drive, Suite 108
Scarborough, Maine 04074-9308
(207) 396-7600
Fax (207) 396-7610
Brunswick Office
81 Medical Center Drive
Suite 1300G
Brunswick, ME 04011
(207) 729-1148
Fax (207)729-2789
Biddeford Office
26 West Cole Road
Biddeford, Maine 04005-9407
(207) 282-0448
Fax (207)286-9126
Sanford Office
27 Industrial Avenue
Sanford, ME 04073
(207)490-7777
Fax (207) 490-7779